Fred E Cohen
Director at CareDx, Inc. (CDNA)
Fred E Cohen has filed 30 insider reports with the SEC since January 2021, as director at CareDx, Inc. (CDNA), director at Intellia Therapeutics, Inc. (NTLA) and director at Kyverna Therapeutics, Inc. (KYTX) and at 2 more companies. In the last 12 months Fred E Cohen bought $1.4M of stock on the open market. The latest filing, on November 4, 2026, reports gift at CareDx, Inc. (CDNA).
- Filings
- 30
- Companies
- 5
- Bought on market
- $1.4M
- Sold on market
- None
Companies where Fred E Cohen is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 140,060 | $74.44 | Nov 4, 2026 | ||||
| Director | 216,653 | $1.4M | $9.35 | $9.77+4.5% | Jun 10, 2026 | ||
| Director | 21,727 | $4.48 | May 29, 2026 | ||||
| Director | 22,693 | $36.16 | Jun 3, 2025 | ||||
| Director | $29.79 | Aug 8, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 3, 2026CDNADirector Cohen Fred E gifted 25,000 shares, decreasing direct ownership by 15% to 140,060 unitsForm 4Gift
- Jun 12, 2026CDNADirector Cohen Fred E was granted 9,795 shares, increasing direct ownership by 6% to 165,060 unitsForm 4Grant or award
- Jun 9, 2026NTLADirector Cohen Fred E was granted 9,200 shares, increasing direct ownership by 4% to 216,653 unitsForm 4Grant or award
- May 27, 2026KYTXDirector Cohen Fred E was granted 5,093 shares, increasing direct ownership by 31% to 21,727 unitsForm 4Grant or award
- Jan 5, 2026+$1.4MNTLADirector Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 unitsForm 4Open-market purchase
- Jun 13, 2025CDNADirector Cohen Fred E was granted 12,103 shares, increasing direct ownership by 8% to 155,265 unitsForm 4Grant or award
- Jun 11, 2025NTLADirector Cohen Fred E was granted 8,000 shares, increasing direct ownership by 16% to 57,453 unitsForm 4Grant or award
- Jun 3, 2025~$1.35MPGNYFred E Cohen plans to sell 62,244 shares (~$1.35M)Form 144Planned sale
- May 29, 2025KYTXDirector Cohen Fred E was granted 16,634 sharesForm 4Grant or award
- Aug 6, 2024URGNSEC Form 4 filed by Director Cohen Fred EForm 4Grant or award
- Jun 14, 2024CDNAAmendment: SEC Form 4 filed by Director Cohen Fred EForm 4Grant or award
- Jun 14, 2024CDNADirector Cohen Fred E was granted 10,570 shares, increasing direct ownership by 8% to 143,162 unitsForm 4Grant or award
- Jun 12, 2024NTLADirector Cohen Fred E was granted 7,737 shares, increasing direct ownership by 19% to 49,453 unitsForm 4Grant or award
- May 23, 2024PGNYCohen Fred E was granted 6,176 shares, increasing direct ownership by 37% to 22,693 unitsForm 4Grant or award
- Sep 7, 2023URGNSEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Jul 26, 2023URGNSEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Jun 16, 2023CDNASEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Jun 14, 2023NTLASEC Form 4 filed by Cohen Fred EForm 4Grant or award
- May 24, 2023PGNYSEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Jan 6, 2023CDNASEC Form 4: Cohen Fred E was granted 1,062 shares, increasing direct ownership by 0.94% to 113,748 unitsForm 4Grant or award
- Oct 24, 2022PGNYSEC Form 4: Cohen Fred E was granted 3,480 shares, increasing direct ownership by 40% to 12,132 unitsForm 4Grant or award
- Oct 4, 2022CDNASEC Form 4: Cohen Fred E was granted 803 shares, increasing direct ownership by 0.72% to 112,686 unitsForm 4Grant or award
- Jun 16, 2022CDNASEC Form 4: Cohen Fred E was granted 4,863 shares, increasing direct ownership by 5% to 111,883 unitsForm 4Grant or award
- Jun 14, 2022NTLASEC Form 4: Cohen Fred E was granted 5,197 shares, increasing direct ownership by 16% to 37,291 unitsForm 4Grant or award
- Jun 8, 2022URGNSEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Oct 24, 2021PGNYSEC Form 4: Cohen Fred E was granted 2,652 shares, increasing direct ownership by 44% to 8,652 unitsForm 4Grant or award
- Jun 23, 2021NTLASEC Form 4: Cohen Fred E was granted 2,094 units of Common StockForm 4Grant or award
- Jun 16, 2021CDNASEC Form 4: Cohen Fred E was granted 1,127 units of Common Stock, increasing direct ownership by 1% to 107,020 unitsForm 4Grant or award
- Jun 7, 2021URGNSEC Form 4 filed by Cohen Fred EForm 4Grant or award
- Jan 20, 2021NTLASEC Form 4: E Fred Cohen exercised 20,000 units of Common Stock at a strike of $13.78, increasing ownership by 200% to 30,000 unitsForm 4Exercise or conversion of a derivative
Also sits on boards with
Officers and directors who share two or more companies with Fred E Cohen.
Compare Fred E Cohen with
- Fred E Cohen vs Beth C Seidenberg2 shared
- Fred E Cohen vs Richard Bryan Riggsbee1 shared
- Fred E Cohen vs Keith Kennedy1 shared
- Fred E Cohen vs Geoffrey Clapp1 shared
- Fred E Cohen vs Peter Anevski1 shared
- Fred E Cohen vs David J Schlanger1 shared
Other insiders at the same companies
- Richard Bryan RiggsbeeCDNA
- Keith KennedyCDNA
- Geoffrey ClappPGNY
- Peter AnevskiPGNY
- David J SchlangerPGNY
- George BickerstaffCDNA
- Jeffrey Adam NovackCDNA
- Mark S. LivingstonPGNY
- Allison SwartzPGNY
- John M LeonardNTLA
- Kevin K GordonPGNY
- Jessica MengCDNA
- Mark SchoenbergURGN
- Jason Drew SmithURGN
- James A. Robinson Jr.URGN
- Christine CournoyerCDNA
Questions about Fred E Cohen
- What is Fred E Cohen's role at CareDx, Inc.?
- Fred E Cohen reports to the SEC as director at CareDx, Inc. (CDNA), according to the latest filing on November 4, 2026. Fred E Cohen has also filed as director at Intellia Therapeutics, Inc. (NTLA), director at Kyverna Therapeutics, Inc. (KYTX), director at Progyny, Inc. (PGNY) and director at UroGen Pharma Ltd. (URGN).
- How many shares does Fred E Cohen own?
- After the latest filing that states it, Fred E Cohen directly owned 140,060 shares of CareDx, Inc. (CDNA), 216,653 shares of Intellia Therapeutics, Inc. (NTLA), 21,727 shares of Kyverna Therapeutics, Inc. (KYTX) and 22,693 shares of Progyny, Inc. (PGNY). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Fred E Cohen bought or sold stock recently?
- The most recent open-market purchase was on January 5, 2026: bought 150,000 shares of Intellia Therapeutics, Inc. (NTLA) for $1.4M at an average of $9.35.
- How do I get alerts when Fred E Cohen files?
- Follow Fred E Cohen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Fred E Cohen filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Fred E Cohen (SEC CIK 0001339358). Totals count each trade once, skipping amendments whose original is on file, from Jan 22, 2021 on. View on SEC EDGAR